To Be Discontinued Tablet Antiviral

Amantadine Hydrochloride Tab · 415 days since initial FDA posting

Brand: AMANTADINE HYDROCHLORIDE

FDA lists Amantadine Hydrochloride Tab as To Be Discontinued (Upsher-Smith Laboratories, LLC).

No availability text on this FDA row.

Amantadine Hydrochloride Tablet: To Be Discontinued

FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.

Shortage Details

Generic Name
Amantadine Hydrochloride Tablet
Manufacturer
Upsher-Smith Laboratories, LLC
Dosage Form
Tablet
Presentation
Amantadine Hydrochloride, Tablet, 100 mg (NDC 0832-0111-03)
Package NDC
0832-0111-03

Status & Timeline

Status
To Be Discontinued
First Reported
Jul 23, 2025
Last Updated
Jul 23, 2025
Therapeutic Category
Antiviral, Neurology

Row fields from the FDA Drug Shortages database via openFDA.

Shortage Reason

Discontinuation of the manufacture of the drug product

Nearby, Other Amantadine Shortage Records

Amantadine Hydrochloride Tablet

Upsher-Smith Laboratories, LLC

Tablet

To Be Discontinued

Amantadine Hydrochloride Capsule

Upsher-Smith Laboratories, LLC

Capsule

To Be Discontinued

Amantadine Hydrochloride Tablet

Upsher-Smith Laboratories, LLC

Tablet

To Be Discontinued

Amantadine Hydrochloride Capsule

Upsher-Smith Laboratories, LLC

Capsule

To Be Discontinued

FDA reason on file: Discontinuation of the manufacture of the drug product. General shortage guidance lives on the tracker hub.

← All Drug Shortages